DMII
Drugs Made In America Acquisition II Corp.
10.20$
+0.0%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|
| – | – | +7.9% | +441,723.5% | +0.8% | +0.9% | +0.9% | |
| – | – | 0.0% | +7,647.2% | -97.1% | +1,251.0% | -38.1% | |
| – | – | -37.1% | +7,070.8% | -99.9% | +155,828.3% | -49.7% | |
| – | – | -37.1% | +7,070.8% | – | – | -49.7% | |
| – | – | – | +21,713.1% | – | – | – | |
| – | – | +16.5% | +5,450.1% | -2.1% | +2.1% | -0.1% | |
| – | – | +16.5% | +106.8% | -55.6% | +121.5% | -3.3% | |
| – | – | +18.9% | – | – | – | +0.0% | |
| – | – | – | – | +2,063.7% | -50.5% | -75.1% | |
| – | – | – | – | +0.9% | +0.9% | +0.9% | |
| – | – | – | – | – | – | – | |
| – | +0.0% | -47.9% | -91.8% | +2,244.2% | -21.5% | +0.0% |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.